Sign up
Log in
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Share
Listen to the news

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 150 points on Wednesday.

Shares of Progress Software Corporation (NASDAQ:PRGS) fell sharply in today's pre-market trading after the company issued first-quarter EPS guidance below estimates.

Progress Software reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.22 per share. The company reported quarterly sales of $215.00 million which beat the analyst consensus estimate of $211.25 million.

Progress Software said it sees first-quarter revenue of $232 million to $238 million versus market estimates of $235.840 million. The company projects adjusted earnings of $1.02 to $1.08 per share, versus expectations of $1.25 per share.

Progress Software shares declined 2.6% to $61.90 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Associated Capital Group, Inc. (NYSE:AC) fell 43.7% to $20.00 in pre-market trading. Associated Capital recently reported estimated fourth quarter and full year results
  • Septerna, Inc. (NASDAQ:SEPN) fell 14.4% to $16.01 in pre-market trading after gaining more than 10% on Tuesday.
  • AnaptysBio, Inc. (NASDAQ:ANAB) declined 12.3% to $14.81 in pre-market trading after gaining over 6% on Tuesday.
  • Marine Products Corporation (NYSE:MPX) dipped 11.3% to $8.04 in pre-market trading. Marine Products will release its financial results for the fourth quarter on Thursday, Jan. 30, before the market opens.
  • Zenas BioPharma, Inc. (NASDAQ:ZBIO) shares fell 8.2% to $7.71 in pre-market trading.
  • GH Research PLC (NASDAQ:GHRS) dipped 7.7% to $8.30 in pre-market trading.
  • Dogness (International) Corporation (NASDAQ:DOGZ) fell 4.5% to $27.47 in pre-market trading.
  • Disc Medicine, Inc. (NASDAQ:IRON) fell 2.7% to $58.88 in pre-market trading as the company announced a proposed $200 million public offering of common stock and pre-funded warrants.

Now Read This:

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.